 Christina Coughlan
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 11 | 2026 | 622 | 2.300 |
Why?
| | Extracellular Vesicles | 9 | 2025 | 171 | 2.040 |
Why?
| | Exosomes | 3 | 2023 | 104 | 0.800 |
Why?
| | Astrocytes | 4 | 2022 | 228 | 0.780 |
Why?
| | Glial Fibrillary Acidic Protein | 3 | 2026 | 125 | 0.750 |
Why?
| | White Matter | 2 | 2023 | 153 | 0.740 |
Why?
| | Gliosis | 2 | 2023 | 29 | 0.720 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2022 | 153 | 0.710 |
Why?
| | Sialyltransferases | 8 | 1999 | 13 | 0.690 |
Why?
| | Amyloid beta-Protein Precursor | 5 | 2022 | 64 | 0.660 |
Why?
| | Ultracentrifugation | 1 | 2020 | 50 | 0.640 |
Why?
| | Healthy Aging | 1 | 2021 | 40 | 0.640 |
Why?
| | Memory, Episodic | 1 | 2021 | 55 | 0.640 |
Why?
| | Amyloid beta-Peptides | 7 | 2026 | 243 | 0.590 |
Why?
| | Neurons | 8 | 2026 | 1639 | 0.560 |
Why?
| | Saccharomyces cerevisiae | 5 | 2022 | 579 | 0.530 |
Why?
| | Proteomics | 4 | 2026 | 1183 | 0.500 |
Why?
| | Peptide Fragments | 3 | 2022 | 691 | 0.460 |
Why?
| | Nanoparticles | 1 | 2020 | 512 | 0.410 |
Why?
| | Cognitive Dysfunction | 3 | 2025 | 464 | 0.410 |
Why?
| | Neurodegenerative Diseases | 2 | 2026 | 150 | 0.390 |
Why?
| | Dexamethasone | 7 | 1999 | 366 | 0.390 |
Why?
| | Biomarkers | 10 | 2026 | 4261 | 0.350 |
Why?
| | Brain Ischemia | 2 | 2025 | 358 | 0.320 |
Why?
| | Herpes Zoster | 3 | 2024 | 315 | 0.320 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2021 | 48 | 0.310 |
Why?
| | Down Syndrome | 4 | 2022 | 522 | 0.310 |
Why?
| | Sialoglycoproteins | 3 | 1997 | 157 | 0.270 |
Why?
| | Protein Folding | 3 | 2005 | 277 | 0.270 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2025 | 161 | 0.260 |
Why?
| | Aging | 4 | 2026 | 1938 | 0.250 |
Why?
| | Interleukin-6 | 3 | 2026 | 770 | 0.250 |
Why?
| | Oligoclonal Bands | 1 | 2026 | 26 | 0.230 |
Why?
| | Herpesvirus 3, Human | 3 | 2024 | 337 | 0.230 |
Why?
| | Neuroblastoma | 3 | 1999 | 174 | 0.230 |
Why?
| | Aged, 80 and over | 9 | 2026 | 8284 | 0.230 |
Why?
| | Stroke | 3 | 2023 | 1262 | 0.220 |
Why?
| | Humans | 41 | 2026 | 144671 | 0.220 |
Why?
| | Plasma | 2 | 2024 | 223 | 0.220 |
Why?
| | Proteome | 2 | 2024 | 515 | 0.220 |
Why?
| | Sodium Bicarbonate | 1 | 2025 | 47 | 0.220 |
Why?
| | Protein Conformation | 2 | 2005 | 935 | 0.220 |
Why?
| | Tetraspanin 28 | 1 | 2024 | 6 | 0.220 |
Why?
| | Intra-Abdominal Fat | 1 | 2025 | 100 | 0.220 |
Why?
| | Chordoma | 1 | 2024 | 17 | 0.210 |
Why?
| | DNA Transposable Elements | 1 | 2025 | 125 | 0.210 |
Why?
| | alpha-Synuclein | 1 | 2024 | 45 | 0.210 |
Why?
| | Acidosis | 1 | 2025 | 105 | 0.210 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2025 | 177 | 0.210 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2024 | 691 | 0.210 |
Why?
| | Amyloidogenic Proteins | 1 | 2024 | 16 | 0.210 |
Why?
| | Aprotinin | 1 | 2004 | 9 | 0.210 |
Why?
| | Mitochondria | 2 | 2025 | 984 | 0.210 |
Why?
| | Varicella Zoster Virus Infection | 2 | 2024 | 27 | 0.200 |
Why?
| | Vacuoles | 1 | 2004 | 38 | 0.200 |
Why?
| | Osteoblasts | 1 | 2024 | 146 | 0.200 |
Why?
| | Glucocorticoids | 3 | 1999 | 528 | 0.200 |
Why?
| | Recombinant Proteins | 2 | 2007 | 1363 | 0.200 |
Why?
| | Carcinogenesis | 1 | 2025 | 227 | 0.200 |
Why?
| | Central Nervous System | 1 | 2026 | 279 | 0.200 |
Why?
| | Animals | 24 | 2025 | 37948 | 0.200 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 729 | 0.200 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 211 | 0.190 |
Why?
| | Bleomycin | 1 | 2024 | 253 | 0.190 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 289 | 0.190 |
Why?
| | Colon | 1 | 2025 | 307 | 0.180 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 99 | 0.180 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 71 | 0.180 |
Why?
| | Apolipoprotein E4 | 1 | 2022 | 41 | 0.180 |
Why?
| | Disease | 1 | 2003 | 98 | 0.180 |
Why?
| | tau Proteins | 2 | 2026 | 115 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 4 | 2011 | 466 | 0.180 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2025 | 294 | 0.180 |
Why?
| | Fatty Acids | 1 | 2025 | 454 | 0.180 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2024 | 630 | 0.170 |
Why?
| | Obesity | 2 | 2025 | 3070 | 0.170 |
Why?
| | Cognition | 3 | 2025 | 1263 | 0.170 |
Why?
| | Immunoglobulin G | 1 | 2026 | 886 | 0.170 |
Why?
| | Aged | 13 | 2026 | 25955 | 0.170 |
Why?
| | Endoplasmic Reticulum | 1 | 2004 | 264 | 0.170 |
Why?
| | Retinal Drusen | 1 | 2021 | 31 | 0.170 |
Why?
| | Peptides | 2 | 2024 | 989 | 0.170 |
Why?
| | Virion | 1 | 2022 | 111 | 0.170 |
Why?
| | Retinal Pigment Epithelium | 1 | 2021 | 79 | 0.170 |
Why?
| | Arteritis | 1 | 2021 | 23 | 0.170 |
Why?
| | Aldosterone | 4 | 1999 | 42 | 0.170 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2022 | 78 | 0.160 |
Why?
| | Chemical Precipitation | 1 | 2020 | 39 | 0.160 |
Why?
| | Cell Polarity | 1 | 2021 | 137 | 0.160 |
Why?
| | Health Status | 1 | 2026 | 834 | 0.160 |
Why?
| | Myelitis | 1 | 2022 | 107 | 0.160 |
Why?
| | Neurofilament Proteins | 3 | 2026 | 79 | 0.160 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2021 | 151 | 0.160 |
Why?
| | Stem Cells | 1 | 2025 | 621 | 0.160 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 669 | 0.160 |
Why?
| | Adipose Tissue | 1 | 2025 | 643 | 0.160 |
Why?
| | Enterovirus D, Human | 1 | 2022 | 87 | 0.160 |
Why?
| | Multiple Sclerosis | 1 | 2026 | 485 | 0.160 |
Why?
| | Amyloid | 1 | 2021 | 90 | 0.160 |
Why?
| | Middle Aged | 13 | 2026 | 35971 | 0.160 |
Why?
| | Cell Movement | 1 | 2024 | 959 | 0.160 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 47 | 0.150 |
Why?
| | Neuromuscular Diseases | 1 | 2022 | 146 | 0.150 |
Why?
| | Inflammation | 3 | 2026 | 2870 | 0.150 |
Why?
| | Chemokine CCL2 | 1 | 2000 | 112 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 3 | 1999 | 480 | 0.150 |
Why?
| | Macular Degeneration | 1 | 2021 | 190 | 0.150 |
Why?
| | Enterovirus Infections | 1 | 2022 | 173 | 0.150 |
Why?
| | Male | 18 | 2026 | 72431 | 0.140 |
Why?
| | Wnt-5a Protein | 1 | 2018 | 24 | 0.140 |
Why?
| | Fibroblasts | 1 | 2024 | 1019 | 0.140 |
Why?
| | Signal Transduction | 4 | 2021 | 5185 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 657 | 0.140 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3523 | 0.140 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2017 | 19 | 0.130 |
Why?
| | Female | 17 | 2026 | 78304 | 0.130 |
Why?
| | Melanoma | 1 | 2024 | 757 | 0.130 |
Why?
| | Kidney | 2 | 2015 | 1495 | 0.130 |
Why?
| | Cell Communication | 2 | 2000 | 325 | 0.130 |
Why?
| | N-Acetylneuraminic Acid | 2 | 1999 | 16 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2025 | 849 | 0.130 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 5 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2025 | 926 | 0.130 |
Why?
| | Aneuploidy | 1 | 2017 | 90 | 0.130 |
Why?
| | Tumor Cells, Cultured | 5 | 2000 | 881 | 0.130 |
Why?
| | Glycosylation | 4 | 2026 | 161 | 0.120 |
Why?
| | Trisomy | 1 | 2017 | 78 | 0.120 |
Why?
| | Brain Chemistry | 1 | 1996 | 116 | 0.120 |
Why?
| | Isoenzymes | 1 | 1996 | 297 | 0.110 |
Why?
| | Proteins | 1 | 2021 | 1016 | 0.110 |
Why?
| | Apoptosis | 3 | 2025 | 2397 | 0.110 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2025 | 46 | 0.110 |
Why?
| | Carcinoma, Hepatocellular | 2 | 1997 | 370 | 0.110 |
Why?
| | Rats | 8 | 2025 | 5570 | 0.110 |
Why?
| | Models, Biological | 1 | 2003 | 1811 | 0.110 |
Why?
| | Cystic Fibrosis | 1 | 2005 | 1166 | 0.110 |
Why?
| | Adult | 8 | 2026 | 40489 | 0.100 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2909 | 0.100 |
Why?
| | Brain | 4 | 2023 | 2934 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4539 | 0.100 |
Why?
| | Mice | 10 | 2025 | 18261 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2021 | 1338 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 262 | 0.100 |
Why?
| | Membrane Proteins | 3 | 2024 | 1159 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 1996 | 590 | 0.090 |
Why?
| | Enzyme Induction | 3 | 1997 | 88 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2015 | 2136 | 0.090 |
Why?
| | Transcription Factor AP-2 | 1 | 2011 | 82 | 0.090 |
Why?
| | Glioma | 1 | 1995 | 429 | 0.080 |
Why?
| | Parkinson Disease | 1 | 2017 | 600 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 627 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5967 | 0.080 |
Why?
| | Membrane Transport Proteins | 1 | 2011 | 153 | 0.080 |
Why?
| | Adrenalectomy | 4 | 1999 | 68 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2021 | 4110 | 0.080 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2026 | 3910 | 0.070 |
Why?
| | Receptors, Nicotinic | 1 | 2011 | 328 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1180 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2573 | 0.070 |
Why?
| | Palliative Care | 1 | 2017 | 1011 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 813 | 0.070 |
Why?
| | Caregivers | 1 | 2017 | 1062 | 0.070 |
Why?
| | DNA-Binding Proteins | 2 | 2025 | 1484 | 0.070 |
Why?
| | Schizophrenia | 1 | 2011 | 443 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2011 | 418 | 0.060 |
Why?
| | Transcription Factors | 2 | 2025 | 1726 | 0.060 |
Why?
| | Liver | 1 | 1996 | 1889 | 0.060 |
Why?
| | Drug Stability | 1 | 2007 | 169 | 0.060 |
Why?
| | Chemokine CXCL5 | 1 | 2026 | 19 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 507 | 0.060 |
Why?
| | Chemokine CXCL9 | 1 | 2026 | 38 | 0.060 |
Why?
| | Golgi Apparatus | 2 | 2004 | 99 | 0.060 |
Why?
| | Polysaccharides | 2 | 2004 | 86 | 0.060 |
Why?
| | Mutation | 4 | 2017 | 4081 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
| | Cytokines | 2 | 2024 | 2045 | 0.060 |
Why?
| | Middle Cerebral Artery | 1 | 2025 | 56 | 0.060 |
Why?
| | Protein Aggregates | 1 | 2026 | 84 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2024 | 376 | 0.060 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2025 | 48 | 0.060 |
Why?
| | DNA Methylation | 2 | 2025 | 664 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2023 | 3603 | 0.050 |
Why?
| | Calnexin | 1 | 2004 | 3 | 0.050 |
Why?
| | Centrifugation, Density Gradient | 1 | 2004 | 36 | 0.050 |
Why?
| | Kinetics | 2 | 1998 | 1603 | 0.050 |
Why?
| | Cycloheximide | 1 | 2004 | 42 | 0.050 |
Why?
| | Concanavalin A | 1 | 2004 | 71 | 0.050 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2004 | 44 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2004 | 90 | 0.050 |
Why?
| | Mass Spectrometry | 1 | 2007 | 743 | 0.050 |
Why?
| | Cell Death | 1 | 2025 | 382 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 69 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 65 | 0.050 |
Why?
| | Fluorescent Dyes | 1 | 2025 | 333 | 0.050 |
Why?
| | Base Sequence | 1 | 2007 | 2177 | 0.050 |
Why?
| | Virus Activation | 1 | 2024 | 95 | 0.050 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2004 | 48 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 25 | 0.050 |
Why?
| | Disulfides | 1 | 2004 | 94 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 341 | 0.050 |
Why?
| | Time Factors | 2 | 2025 | 7140 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2025 | 261 | 0.050 |
Why?
| | Sucrose | 1 | 2004 | 114 | 0.050 |
Why?
| | Hippocampus | 2 | 2022 | 966 | 0.050 |
Why?
| | Chemokines, CXC | 1 | 2003 | 68 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2004 | 145 | 0.050 |
Why?
| | Carbohydrate Sequence | 3 | 1999 | 29 | 0.050 |
Why?
| | Neurites | 1 | 2023 | 50 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2023 | 75 | 0.050 |
Why?
| | beta Catenin | 1 | 2025 | 252 | 0.050 |
Why?
| | Plasmids | 1 | 2004 | 375 | 0.050 |
Why?
| | Interferon-gamma | 1 | 2026 | 781 | 0.050 |
Why?
| | Imipramine | 1 | 2022 | 11 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 86 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2026 | 5870 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 210 | 0.050 |
Why?
| | Chemokines | 1 | 2003 | 218 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2591 | 0.050 |
Why?
| | Retinal Ganglion Cells | 1 | 2003 | 115 | 0.050 |
Why?
| | Densitometry | 1 | 2022 | 35 | 0.040 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 73 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 154 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2024 | 475 | 0.040 |
Why?
| | Virus Internalization | 1 | 2022 | 65 | 0.040 |
Why?
| | Viral Proteins | 1 | 2024 | 353 | 0.040 |
Why?
| | Polymerization | 1 | 2022 | 130 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 849 | 0.040 |
Why?
| | Catalysis | 1 | 2022 | 319 | 0.040 |
Why?
| | Cattle | 1 | 2004 | 975 | 0.040 |
Why?
| | Chromatin | 1 | 2025 | 554 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1078 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2025 | 3109 | 0.040 |
Why?
| | Lectins | 2 | 1998 | 45 | 0.040 |
Why?
| | Interneurons | 1 | 2022 | 125 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2000 | 23 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2023 | 244 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 293 | 0.040 |
Why?
| | Immune System | 1 | 2022 | 178 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2021 | 273 | 0.040 |
Why?
| | Retina | 1 | 2003 | 319 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 317 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2033 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1995 | 0.040 |
Why?
| | Teratocarcinoma | 1 | 2000 | 2 | 0.040 |
Why?
| | Phagocytosis | 1 | 2021 | 296 | 0.040 |
Why?
| | Receptors, Dopamine D2 | 1 | 2000 | 93 | 0.040 |
Why?
| | Intracellular Space | 1 | 2020 | 64 | 0.040 |
Why?
| | Organoids | 1 | 2021 | 139 | 0.040 |
Why?
| | Acyclovir | 1 | 2020 | 96 | 0.040 |
Why?
| | Extracellular Space | 1 | 2020 | 119 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1886 | 0.040 |
Why?
| | Phytohemagglutinins | 1 | 1999 | 29 | 0.040 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 98 | 0.040 |
Why?
| | Cell Line | 2 | 2022 | 2821 | 0.040 |
Why?
| | Cerebral Palsy | 1 | 2021 | 137 | 0.040 |
Why?
| | Thrombosis | 1 | 2023 | 396 | 0.040 |
Why?
| | DNA, Viral | 1 | 2021 | 357 | 0.040 |
Why?
| | Nicotine | 1 | 2021 | 334 | 0.040 |
Why?
| | Genotype | 1 | 2004 | 1847 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 601 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 269 | 0.040 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1319 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 231 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1437 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2011 | 2815 | 0.030 |
Why?
| | MicroRNAs | 1 | 2024 | 689 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2000 | 243 | 0.030 |
Why?
| | Asialoglycoproteins | 1 | 1997 | 2 | 0.030 |
Why?
| | Fetuins | 1 | 1997 | 3 | 0.030 |
Why?
| | Cytidine Monophosphate N-Acetylneuraminic Acid | 1 | 1997 | 3 | 0.030 |
Why?
| | Nervous System | 1 | 1998 | 69 | 0.030 |
Why?
| | Protein Binding | 1 | 2004 | 2243 | 0.030 |
Why?
| | alpha-Fetoproteins | 1 | 1997 | 42 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 200 | 0.030 |
Why?
| | Gene Dosage | 1 | 2017 | 148 | 0.030 |
Why?
| | Tretinoin | 1 | 1998 | 124 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 42 | 0.030 |
Why?
| | Heterozygote | 1 | 2017 | 313 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 1996 | 15 | 0.030 |
Why?
| | Glycoproteins | 1 | 1998 | 353 | 0.030 |
Why?
| | Oligosaccharides | 1 | 1996 | 60 | 0.030 |
Why?
| | Parietal Lobe | 1 | 1996 | 60 | 0.030 |
Why?
| | Glutathione Reductase | 1 | 2015 | 24 | 0.030 |
Why?
| | Peroxiredoxins | 1 | 2015 | 26 | 0.030 |
Why?
| | Substrate Specificity | 1 | 1996 | 392 | 0.030 |
Why?
| | Brain Stem | 1 | 1996 | 97 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2015 | 96 | 0.030 |
Why?
| | Fetus | 1 | 2000 | 800 | 0.030 |
Why?
| | Adolescent | 2 | 2025 | 22409 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 1998 | 285 | 0.030 |
Why?
| | Acetylation | 1 | 2015 | 249 | 0.030 |
Why?
| | Aldehydes | 1 | 2015 | 141 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 566 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 209 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2017 | 545 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 765 | 0.030 |
Why?
| | Cerebellum | 1 | 1996 | 224 | 0.030 |
Why?
| | Glutathione | 1 | 2015 | 366 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 303 | 0.020 |
Why?
| | Cell Differentiation | 2 | 1998 | 2037 | 0.020 |
Why?
| | Risk Assessment | 1 | 2023 | 3729 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2017 | 905 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2184 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 1995 | 441 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 524 | 0.020 |
Why?
| | Risk Factors | 1 | 2026 | 10796 | 0.020 |
Why?
| | SEC Translocation Channels | 1 | 2011 | 9 | 0.020 |
Why?
| | Amino Acids | 1 | 2015 | 521 | 0.020 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2011 | 94 | 0.020 |
Why?
| | Lung | 1 | 2024 | 4089 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2011 | 374 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 177 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 187 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11790 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2011 | 334 | 0.020 |
Why?
| | HeLa Cells | 1 | 2011 | 632 | 0.020 |
Why?
| | Protein Transport | 1 | 2011 | 437 | 0.020 |
Why?
| | Qualitative Research | 1 | 2017 | 1668 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 631 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14122 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 11735 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1246 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2201 | 0.020 |
Why?
| | Child | 1 | 2025 | 22600 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1468 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17149 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2003 | 120 | 0.010 |
Why?
| | Chick Embryo | 1 | 2003 | 132 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2003 | 72 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2003 | 81 | 0.010 |
Why?
| | Chemokine CXCL12 | 1 | 2003 | 86 | 0.010 |
Why?
| | Nerve Growth Factors | 1 | 2003 | 78 | 0.010 |
Why?
| | Receptors, CXCR4 | 1 | 2003 | 91 | 0.010 |
Why?
| | Infant | 1 | 2017 | 10023 | 0.010 |
Why?
| | Cell Count | 1 | 2003 | 320 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2003 | 205 | 0.010 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 125 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 287 | 0.010 |
Why?
| | Apelin Receptors | 1 | 2000 | 4 | 0.010 |
Why?
| | Dopamine D2 Receptor Antagonists | 1 | 2000 | 5 | 0.010 |
Why?
| | Apelin | 1 | 2000 | 10 | 0.010 |
Why?
| | Adipokines | 1 | 2000 | 57 | 0.010 |
Why?
| | Receptors, Virus | 1 | 2000 | 96 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2000 | 93 | 0.010 |
Why?
| | Cell Survival | 1 | 2003 | 1092 | 0.010 |
Why?
| | Primates | 1 | 2000 | 133 | 0.010 |
Why?
| | Swainsonine | 1 | 1999 | 1 | 0.010 |
Why?
| | 1-Deoxynojirimycin | 1 | 1999 | 1 | 0.010 |
Why?
| | Mannosidases | 1 | 1999 | 3 | 0.010 |
Why?
| | Neuraminidase | 1 | 1999 | 25 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 335 | 0.010 |
Why?
| | Phosphorylation | 1 | 2003 | 1704 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 924 | 0.010 |
Why?
| | Biological Transport | 1 | 1999 | 418 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2000 | 572 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2000 | 1251 | 0.010 |
Why?
| | Solubility | 1 | 1998 | 236 | 0.010 |
Why?
| | Blotting, Western | 1 | 1999 | 1161 | 0.010 |
Why?
| | Pituitary Neoplasms | 1 | 1999 | 190 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 733 | 0.010 |
Why?
| | HIV-1 | 1 | 2000 | 897 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2000 | 1505 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2000 | 1984 | 0.010 |
Why?
|
|
Coughlan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|